1,3-Benzothiazole-5-Carboxylic Acid

1,3-Benzothiazole-5-carboxylic acid (CAS 68867-14-1) presents as a crystalline off-white powder with an assay typically exceeding 98.5% by HPLC (peak area, 254 nm). Its molecular formula is C₈H₅NO₂S, yielding a formula weight of 179.20 g·mol⁻¹. The compound melts within the range 262–267 °C, accompanied by decomposition, a thermal behavior that precludes melt-phase processing and mandates solution-phase derivatization. Storage in sealed containers under dry nitrogen at 2–8 °C is prescribed; exposure to ambient humidity above 60% RH induces hydration to a monohydrate form, which shifts the melting point downward by approximately 15 °C and complicates gravimetric dispensing during parallel synthesis campaigns. The material is classified under Harmonized System code 2934.99 and is registered under EU REACH with a minimum purity threshold of 97.0% for tonnage band I–10.

What structural feature distinguishes 5-carboxylic substitution from the more common 2-carboxy isomer?

The benzothiazole nucleus presents three non-equivalent aromatic C–H positions susceptible to electrophilic functionalization: C-4, C-5, and C-6, with C-5 lying meta to the endocyclic nitrogen and para to the sulfur atom. In 1,3-benzothiazole-5-carboxylic acid, the electron density distribution diverges markedly from that of 1,3-benzothiazole-2-carboxylic acid (CAS 3622-35-3). The 5-carboxy group deactivates the fused benzene ring more uniformly than the 2-carboxy substituent, which exerts a strong electron-withdrawing influence directly on the thiazole ring. This differential activation is reflected in Hammett σ_meta values of approximately +0.37 for the 5-position versus +0.51 for the 2-position substituent when the carboxylic acid is converted to its methyl ester. Consequently, nucleophilic aromatic substitution at the 6-position becomes kinetically accessible under milder conditions for the 5-carboxy derivative — a reactivity window exploited in the synthesis of 6-amino-1,3-benzothiazole-5-carboxylic acid intermediates used in kinase inhibitor scaffolds.

Metal-catalyzed cross-coupling under basic conditions: a processing conflict

Bulk amidation of 1,3-benzothiazole-5-carboxylic acid via the acid chloride route imposes severe equipment constraints. Conversion to the acid chloride using thionyl chloride in refluxing dichloromethane (40 °C jacket temperature, glass-lined reactor) generates HCl and SO₂, necessitating a caustic scrubber loop rated for 50 kg/h off-gas flow. The acid chloride itself hydrolyzes exothermically with a half-life of less than 90 seconds in unbuffered water at 25 °C. When the subsequent coupling with primary amines is performed in DMF at 0–5 °C, the free carboxylic acid is often regenerated by residual moisture, lowering isolated yields to 45–60% at scales above 100 g. An alternative activation pathway — employing EDC·HCl and HOBt in anhydrous NMP — boosts conversion to 88–93% on a 5 kg batch size, provided the NMP is dried over 4 Å molecular sieves to a water content ≤50 ppm as confirmed by Karl Fischer titration per ASTM E203-16. Process records from pilot-plant campaigns at 20 L volume reveal that omission of the pre-drying step results in a 12–18% absolute yield loss, attributed to competitive hydrolysis of the active ester.

The compound has been deployed in the preparation of bis(benzothiazole) diamide ligands for copper(I)-catalyzed azide-alkyne cycloaddition. In one documented protocol, coupling of 1,3-benzothiazole-5-carboxylic acid with 1,2-diaminocyclohexane in the presence of HATU and DIPEA in DMF yielded a C₂-symmetric ligand that accelerated the click reaction with a rate constant of 0.82 M⁻¹·s⁻¹ in water/tert-butanol (1:1), a factor of 2.4 over the analogous 6-carboxy-derived ligand. The enhancement is ascribed to a pre-organized binding pocket formed by the 5-substituted benzothiazole rings, placing the copper center within 3.2 Å of the alkyne substrate as inferred from DFT-optimized geometries.

When the target scaffold demands a benzothiazole C-5 vector: agrochemical MBI candidates

The 5-carboxy motif maps onto the pharmacophore of several mitochondrial complex II inhibitors under development with inhibition constants (IC₅₀) in the nanomolar range against Zymoseptoria tritici. In these structures, the carboxylic acid is converted to an N-methylamide to mimic the natural ubiquinone head group, positioning the benzothiazole sulfur within hydrogen-bonding distance of Ser⁸³ of the succinate dehydrogenase iron-sulfur subunit. Field trial data abstracted from regulatory submissions indicate that the 5-substituted benzothiazole amide achieved 85% control of septoria leaf blotch at application rates of 75 g a.i./ha, whereas the corresponding 6-substituted analogue required 125 g a.i./ha for equivalent efficacy. The difference is attributed to slower metabolic oxidation of the 5-substituted benzothiazole ring in planta, as measured by radiolabeled residue studies where the 5-isomer showed a DT₅₀ of 4.2 days versus 2.8 days for the 6-isomer in wheat foliage.

Compatibility with common formulants is a critical differentiator. The free acid exhibits a sharp drop in suspension stability when tank-mixed with polyethoxylated tallow amine (POEA) surfactants below pH 5.0, leading to flocculation visible as sediment in spray-tank filters after 30 minutes of recirculation. This limitation is circumvented by pre-salification with triethanolamine (TEA) to form the water-soluble TEA salt, which maintains 98% solubility after 6 hours at pH 4.8 in a simulated spray solution per CIPAC MT 46.3. The TEA salt, however, introduces a 9% weight dilution of active content and must be handled in stainless steel vessels (AISI 316L) to avoid copper-ion-catalyzed degradation.

Another distinguishing characteristic of the 5-carboxy isomer versus the 2-and 6-isomers is its behavior toward decarboxylative cross-coupling. When subjected to Pd(PPh₃)₄ (5 mol%) and Cs₂CO₃ in N-methyl-2-pyrrolidone at 160 °C, 1,3-benzothiazole-5-carboxylic acid undergoes decarboxylative arylation with 4-iodotoluene in 72% isolated yield, affording 5-(p-tolyl)benzothiazole. The 6-carboxy isomer delivers only 38% yield under identical conditions, a consequence of the lower electron density at the position para to the carboxylate in the 6-substituted intermediate. This reactivity differential has been leveraged in the divergent synthesis of arylated benzothiazole libraries for high-throughput screening.

Specifications, residual impurities, and batch-to-batch variability in commercial supplies

Technical dossiers from ISO 9001:2015-certified manufacturers list the following typical lot-release criteria: appearance (off-white powder, consistent with reference standard lot), identification (FTIR matching library spectrum with peak correlation ≥0.98), assay by HPLC (≥98.0%, area normalization), water content (≤0.5% by KF), and residue on ignition (≤0.1%). Trace levels of the 5-bromo precursor, 1,3-benzothiazole-5-bromide, are controlled below 0.2% by GC-MS, as this impurity can act as a chain-termination agent in Suzuki polycondensations when the carboxylic acid is used as a monomer end-cap. One production campaign recorded a batch failure at 15 kg scale when the bromo impurity spiked to 1.8% due to incomplete lithiation/carboxylation; the material was reworked by reslurrying in 2 M aqueous NaOH and toluene, reducing the bromide content to 0.08%, though overall recovery dropped to 62%.

Users in parallel medicinal chemistry routinely aliquot the compound into tared vials under dry argon using an automated powder dispenser (e.g., Chemspeed SWAVE). Static charge accumulation on the crystalline powder can lead to mass deviations exceeding ±5% at target masses below 20 mg; mitigation involves ionizing bars or humidification of the glovebox to 45% RH, though the latter must be balanced against the hydration threshold. Published data for the optimal dispense-unit humidity setpoint balancing static dissipation and water uptake are limited, but in-house data from a major pharma partner indicate that a 35–40% RH window minimized both variance and monohydrate formation over a 24-hour period.

What distinguishes this intermediate from benzoxazole and benzimidazole analogues?

Replacement of the benzothiazole sulfur with oxygen (benzoxazole-5-carboxylic acid, CAS 148836-29-3) or nitrogen (1H-benzo[d]imidazole-5-carboxylic acid, CAS 15788-16-6) alters both the hydrogen-bonding capacity and the lipophilicity of the derived amides. The sulfur atom in 1,3-benzothiazole-5-carboxylic acid provides a +0.8 logP unit increment over the benzoxazole congener, as calculated by the Crippen fragmentation method, while retaining fewer hydrogen-bonded water molecules in the first solvation shell compared to benzimidazole. In a congeneric series of thrombin inhibitors, the 5-carboxybenzothiazole-derived P3 fragment yielded a K_i of 8.2 nM, whereas the benzoxazole analog lost a factor of 12 in potency, largely attributable to the loss of a sulfur-π interaction with Trp²¹⁵ confirmed by X-ray crystallography (PDB entry 3F68). Yet this same sulfur introduces a metabolic liability: CYP3A4-mediated S-oxidation generates a sulfoxide metabolite with an unbound clearance (CL_int,u) of 18 μL/min/pmol in human liver microsomes, 4.5-fold higher than the corresponding sulfone. The benzoxazole and benzimidazole cores lack this oxidative soft spot, making them structurally superior when hepatic extraction ratios exceeding 0.7 must be avoided. The 5-carboxy substitution does not modulate the S-oxidation rate compared to the 6-carboxy analogue, but conjugating the carboxylic acid to a polar polyethylene glycol chain reduces microsomal turnover by 62%.

At pilot scale, the thiazole ring sulfur also poses a catalyst-poisoning risk. In hydrogenation steps performed downstream (e.g., nitro reductions on the benzothiazole scaffold), palladium-on-carbon (5% Pd/C) activity diminished by 20–30% after three recycles when the substrate contained the 5-carboxybenzothiazole moiety, compared to 5–8% activity loss with the benzoxazole equivalent. This is attributed to strong Pd–S binding verified by XPS showing a shift in Pd 3d_5/2 binding energy from 335.0 eV to 336.2 eV in poisoned catalysts. A sulfur-resistant catalyst system, such as a Raney nickel slurry in ethanol at 45 psig H₂, alleviates this poisoning but requires post-filtration chelating resin treatment (Lewatit TP 207) to remove leached nickel below 2 ppm.

Differences from other heterocyclic carboxylic acids also impinge on safety protocols during scale-up. Differential scanning calorimetry (DSC) at 10 K/min reveals an exotherm onset at 291 °C with an energy release of −820 J/g, placing 1,3-benzothiazole-5-carboxylic acid in the Class 3 decomposition category per the Yoshida correlation. While this is manageable in batch processes, continuous-flow reactors with channel diameters below 1 mm are recommended for N-acylation reactions run above 180 °C to maintain the thermal diffusion time constant below the adiabatic induction time. The benzoxazole analogue decomposes with a substantially lower enthalpy (−490 J/g), offering a wider safe processing window but at the cost of the aforementioned potency decrement.